Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "Treatment For Ovarian Cancer"

OXiGENE Announces Results of Phase 2 Study of CA4P in Recurren...

Study met primary endpoint of improvement in progression free survival Preliminary data show improvement in overall survival of 2.6 months SOUTH SAN FRANCISCO, Calif., May 24, 2016 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a ... 4 Traders, 4 days ago
Reply to B. Abderrahman and V. C. Jordan [CORRESPONDENCE] Journal of Clinical Oncology, 4 days ago
[x]  

9 images for Treatment For Ovarian Cancer

Irish Times, 3 weeks ago
NBCNews.com, 1 month ago
Fox Chase Cancer Center, 3 weeks ago
Hospitality-Lab.com, 1 month ago
NBC Washington DC, 1 month ago
OncLive, 1 month ago
Medical Xpress, 1 month ago
First Post.com, 1 month ago
BMC, 1 month ago
FOXNews.com

Immunotherapy may aid ovarian cancer chemotherapy resistance, study suggests

Ovarian cancer is one of the deadliest cancers among American women, in part because the cancer develops a resistance to chemotherapy. In a new study, researchers at the University of Michigan at Ann Arbor suggest that adding immunotherapy to ...
 FOXNews.com4 days ago Immunotherapy may aid ovarian...  DailyNews724.com4 days ago T Cells Help Reverse Ovarian Cancer ...  Genetic Engineering News4 days ago This Is Why Ovarian Cancer Becomes Resistant To Chemotherapy  Tech Times4 days ago
[x]  

Market Research Rerports Inc: Global Ovarian Cancer Treatment Drugs Industry 2016 Market Report; Launched via MarketResearchReports.com

Market Research Reports, Inc. has announced the addition of "Global Ovarian Cancer Treatment Drugs Industry 2016 Market Research Report" research report to their website www.MarketResearchReports.com 2016 Global Ovarian Cancer Treatment Drugs ...
 Bloomberg3 days ago Global Ovarian Cancer Treatment Drugs Industry 2016 Market Report; Launched via MarketResearchReports.com  Digital Journal3 days ago

Novocure Enrolls Last Patient in INNOVATE Trial Testing Tumor Treating Fields Plus Paclitaxel in Recurrent Ovarian Cancer

ST. HELIER, Jersey--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR ) announced today that the last patient has been enrolled in the INNOVATE trial, a phase 2 pilot trial testing Tumor Treating Fields (TTFields) therapy in combination with weekly ...
 Benzinga.com1 week ago NOVOCURE : Enrolls Last Patient in INNOVATE Trial Testing Tumor Treating Fields Plus Paclitaxel in Recurrent Ovarian Cancer  4 Traders1 week ago
[x]  

New Insights on Ovarian Cancer Offers Clues for Treatment Strategies

Ovarian cancer is the fifth most common cancer and kills about 14,000 women each year in the United States.
 Med India2 months ago

Cancer Survivorship: Managing Hot Flashes

Categories: Breast Cancer, News, Ovarian Cancer, Women and Cancer Magazine Hot flashes are a common side effect of treatment in people with hormone-dependent cancers, such as breast and prostate cancer. Hormone replacement therapy, which may be used ...
 CancerConnect.com5 days ago

Northwest Arkansas Treatment Center First Site Initiated in Global Research on Ovarian Cancer

Highlands Oncology Group Will Collaborate To Research Immunotherapy For Ovarian Cancer Rogers, AR - May 20, 2016 - ( Newswire.com ) ​​Highlands Oncology Group (Highlands), Northwest Arkansas leading cancer research group, is at the forefront ...
 Minyanville1 week ago
[x]  
STV.tv

Research unit named after 34-year-old ovarian cancer victim

Nicola Murray: With her father Lenny on her wedding day. A new research centre aiming to improve treatment for women with ovarian cancer has been named after a34-year-oldwho lost her battle with the illness. The Nicola Murray Centre for Ovarian ...
 STV.tv1 week ago Ovarian cancer centre to target treatment  The University of Edinburgh1 week ago
Finchannel.com

AstraZeneca's Fulvestrant Met Its Primary Endpoint as First-Line Treatment in a Phase III Trial for HR+ Advanced Breast Cancer

AstraZeneca today announced positive results from the Phase III FALCON trial comparing fulvestrant 500mg to anastrozole 1mg for the treatment of locally-advanced or metastatic breast cancer, in postmenopausal women who have not had prior hormonal ...
 Benzinga.com1 day ago AstraZeneca's Faslodex met primary endpoint in first-line treatment of advanced breast cancer  MyNewsDesk1 day ago ASTRAZENECAS FASLODEX MET PRIMARY ENDPOINT IN FIRST-LINE TREATMENT OF ADVANCED BREAST CANCER  PM 3601 day ago AstraZeneca's gastric cancer drug falls short in phase 3  BioPharma Dive1 week ago
[x]  

Positive results from AstraZeneca Faslodex trial

ASTRAZENECA'S FASLODEX MET PRIMARY ENDPOINT IN FIRST-LINE TREATMENT OF ADVANCED BREAST CANCER AstraZeneca today announced positive results from the Phase III FALCON trial comparing Faslodex 500mg (fulvestrant) to Arimidex 1mg (anastrozole) for the ...
 London Stock Exchange1 day ago Angle PLC Placing  ADVFN UK3 days ago AstraZeneca PLC Positive results from AstraZeneca Faslodex trial  ADVFN UK1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Ovarian Cancer
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less